Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from RDUS

4 Analysts Have This to Say About Radius Health

Analysts have provided the following ratings for Radius Health (NASDAQ:RDUS) within the last quarter:

Benzinga · Jun 24, 2022

Bone Health Focused Radius Health Goes Private In $890M Deal

Radius Health Inc (NASDAQ:RDUS) will be acquired by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million, including the assumption of debt and assuming full payment of the CVR (Contingent Value Right). Gurnet Point and Patient Square will pay $10.00 per share in cash plus a…

Benzinga · Jun 23, 2022

Menarini, Radius Health's Elacestrant Prolongs Progression Free Survival In Breast Cancer

The Menarini Group and Radius Health Inc's (NASDAQ: RDUS) data from the phase 3 EMERALD trial evaluating elacestrant for ER+/HER2- advanced or metastatic breast cancer were published in the Journal of Clinical Oncology.

Benzinga · May 20, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap: Radius Health Q1 Earnings

Radius Health (NASDAQ:RDUS) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

3 Healthcare Stocks Under $10 to Buy in May

The healthcare industry is expected to grow significantly this year, driven by sustained demand amid surging chronic diseases worldwide, the increasing health needs of an aging population, and generally increasing healthcare expenditure. Furthermore, digital integration in healthcare systems and technologies should fuel the industry's growth. Given rosy growth prospects, we…

StockNews.com · Apr 28, 2022

5 Pharmaceutical Stocks Under $10 to Buy Right Now

Supportive federal policies to boost medical research and development, tech integration, and robust demand are factors that are expected to drive the long-term growth of the pharmaceutical industry. Thus, we think it could be wise to bet on quality pharmaceutical stocks Catalyst Pharmaceuticals (CPRX), Radius Health (RDUS), Assertio Holdings (ASRT),…

StockNews.com · Apr 25, 2022

Radius Health: A Biotech Stock Worth Buying Now?

With continuing investments in research and development to extend human lifespans and improve the quality of life, the biotech industry looks poised for growth. RDUS is a fundamentally strong player in this space. So, let’s discuss if it is wise to bet on the name amid the current market volatility.…

StockNews.com · Apr 13, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

595 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical – Pharmaceuticals

Assertio Holdings Inc

19 stories

Catalyst Pharmaceuticals Inc

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.